The report covers forecast and analysis for the nanobiotechnology market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the nanobiotechnology market along with the impact they have on the demand over the forecast period.Additionally, the report includes the study of opportunities available in the nanobiotechnology market on a global level.
In order to give the applications of this report a comprehensive view on the nanobiotechnology. To understand the competitive landscape in the market, an analysis of Porter&rsquos Five Forces model for the nanobiotechnology market has also been included. The study encompasses a market attractiveness analysis, wherein service segments and application segments are benchmarked based on their market size, growth rate and general attractiveness.
The study provides a decisive view on the nanobiotechnology market by segmenting the market based on services, applications and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Key application of nanobiotechnology market covered under this study includes discovery, drug delivery, diagnostics and other. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. This segmentation includes demand for nanobiotechnology based on individual applications in all the regions and countries.
The report also includes detailed profiles of end players such as Calando Pharmaceuticals Inc., Advanced Sensor Technologies, Affymetrix, Gilead Sciences, Applied Nanotech, Advectus Life Sciences, and Elan Pharmaceuticals and others. The detailed description of players includes parameters such as company overview, financial overview, business and recent developments of the company.
This report segments the global nanobiotechnology market as follows:
Global Nanobiotechnology market: Application Segment Analysis
Drug Discovery
Drug Delivery
Diagnostics
Others
Global Nanobiotechnology market: Regional Segment Analysis
North America
U.S.
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
Table of Content
Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global nanobiotechnology market, 2015 – 2021 (USD Million)
2.2. Global nanobiotechnology market : Snapshot
Chapter 3. Nanobiotechnology– Market Dynamics
3.1. Introduction
3.2. Market drivers
3.2.1. Global nanobiotechnology market drivers: Impact analysis
3.2.2. Emerging Technology
3.3. Market restraints
3.3.1. Global nanobiotechnology market restraints: Impact analysis
3.3.2. High cost
3.4. Opportunities
3.4.1. Growing demand pharmaceutical market
3.5. Porter’s five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by application segment
3.6.2. Market attractiveness analysis, by regional segment
Chapter 4. Global Nanobiotechnology Market – Competitive Landscape
4.1. Company market share, 2015 (Subject To Data Availability)
Chapter 5. Global Nanobiotechnology Market – Application Segment Analysis
5.1. Global nanobiotechnology market: Application overview
5.1.1. Global nanobiotechnology market revenue share, by application, 2015 – 2021
5.2. Drug Discovery
5.2.1. Global nanobiotechnology market for drug discovery, 2015 – 2021 (USD Million)
5.3. Drug Delivery
5.3.1. Global nanobiotechnology market for drug delivery, 2015 – 2021 (USD Million)
5.4. Diagnostics
5.4.1. Global nanobiotechnology market for diagnostics, 2015 - 2021 (USD Million)
5.5. Others
5.5.1. Global nanobiotechnology market for other application, 2015 – 2021 (USD Million)
Chapter 6. Global Nanobiotechnology Market – Regional Segment Analysis
6.1. Global nanobiotechnology market: Regional overview
6.1.1. Global nanobiotechnology market revenue share, by region, 2015 – 2021
6.2. North America
6.2.1. North America nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.3. Europe
6.3.1. Europe nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.3.2. Germany
6.3.2.1. Germany nanobiotechnology market revenue, by application, 2015 – 2021 , (USD Million)
6.3.3. France
6.3.3.1. France nanobiotechnology market revenue, by application, 2015 – 2021 , (USD Million)
6.3.4. UK
6.3.4.1. UK nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific nanobiotechnology market revenue, by application, 2015 – 2021 , (USD Million)
6.4.2. China
6.4.2.1. China nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.4.3. Japan
6.4.3.1. Japan nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.4.4. India
6.4.4.1. India nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.5. Latin America
6.5.1. Latin America nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
Chapter 7. Company Profile
7.1. Calando Pharmaceuticals Inc
7.1.1. Overview
7.1.2. Financials
7.1.3. Product portfolio
7.1.4. Business strategy
7.1.5. Recent developments
7.2. Advanced Sensor Technologies
7.2.1. Overview
7.2.2. Financials
7.2.3. Product portfolio
7.2.4. Business strategy
7.2.5. Recent developments
7.3. Gilead Sciences
7.3.1. Overview
7.3.2. Financials
7.3.3. Product portfolio
7.3.4. Business strategy
7.3.5. Recent developments
7.4. Applied Nanotech
7.4.1. Overview
7.4.2. Financials
7.4.3. Product portfolio
7.4.4. Business strategy
7.4.5. Recent developments
7.5. Advectus Life Sciences
7.5.1. Overview
7.5.2. Financials
7.5.3. Product portfolio
7.5.4. Business strategy
7.5.5. Recent developments
7.6. Elan Pharmaceuticals
7.6.1. Overview
7.6.2. Financials
7.6.3. Product portfolio
7.6.4. Business strategy
7.6.5. Recent developments
7.7. Affymetrix
7.7.1. Overview
7.7.2. Financials
7.7.3. Product portfolio
7.7.4. Business strategy
7.7.5. Recent developments
